Clinical trial
Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
NCT04739410 is registered in ClinicalTrials.gov with FMH College of Medicine and Dentistry as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
- Lead sponsor
- FMH College of Medicine and Dentistry
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 1, 2020
- Completion date
- June 30, 2020
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19